Fundz

Inquis Medical raised $40M in a Series B financing led by Marshall Wace to advance the Aventus Thrombectomy System for venous thromboembolic diseases.

PRIVATENov 04, 2024

Amount Raised

$40 Million

Round Type

Series B

Menlo ParkBiotechnologyHealth CareMedical

Investors

Pierre LamondMarshall WaceShangbay CapitalEnPointe VenturesYu Star

Description

Inquis Medical has successfully closed a $40 million Series B financing round, led by Marshall Wace. This funding will help accelerate the development and commercialization of their advanced thrombectomy technologies.

Quick answer

Inquis Medical raised $40 Million in a Series B round, dated November 4, 2024. Investors: Pierre Lamond, Marshall Wace, Shangbay Capital, EnPointe Ventures and Yu Star. Inquis Medical is based in Menlo Park, California, United States.

How much did Inquis Medical raise?
Inquis Medical raised $40 Million in a Series B round on November 4, 2024.
Who invested in Inquis Medical?
Pierre Lamond, Marshall Wace, Shangbay Capital, EnPointe Ventures and Yu Star are named as investors in this round.
What does Inquis Medical do?
Inquis Medical is a clinical-stage medical device company focused on peripheral vascular innovations.
Where is Inquis Medical based and how big is it?
Inquis Medical is based in Menlo Park, California, United States.
Who are the decision-makers at Inquis Medical?
Fundz holds 1 contact at Inquis Medical. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Medical and Biotechnology around the same time

Companies in the same sectors as Inquis Medical that raised within 45 days of this round, from Fundz verified event records.

  • SpinaFX raised $5.3M (Series B) on December 19, 2024.
  • Sotelix Endoscopy raised $1.7M (Seed) on December 19, 2024.
  • FastWave Medical raised $19M (Funding Round) on December 17, 2024.
  • Flow Medical raised $5M (Seed) on December 17, 2024.
  • Fluid Biomed raised $27M (Series A) on December 16, 2024.
  • Fibroheal Woundcare raised $742K (Pre-Series A) on December 15, 2024.

Who to call at Inquis Medical, and when

A new round usually means Inquis Medical is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Inquis Medical raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Inquis Medical, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Inquis Medical. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Inquis Medical

Location

Menlo Park, California, United States

About

Inquis Medical is a clinical-stage medical device company focused on peripheral vascular innovations. The company is developing next generation thrombectomy technology that offers physicians improved control and precision, enhances procedural efficiency, and minimizes blood loss. Founded in 2020, Inquis Medical is led by a seasoned executive team with over three decades of combined experience in developing, launching, and supporting novel medical devices that address unmet clinical needs and deliver lasting impact.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Inquis Medical raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Inquis Medical's next move

See what Strategic adds

Funding Insights

What this usually means
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach

Inquis Medical raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.